221 related articles for article (PubMed ID: 24657531)
21. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.
Debruyne DN; Dries R; Sengupta S; Seruggia D; Gao Y; Sharma B; Huang H; Moreau L; McLane M; Day DS; Marco E; Chen T; Gray NS; Wong KK; Orkin SH; Yuan GC; Young RA; George RE
Nature; 2019 Aug; 572(7771):676-680. PubMed ID: 31391581
[TBL] [Abstract][Full Text] [Related]
22. Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant.
Loukinov D; Ghochikyan A; Mkrtichyan M; Ichim TE; Lobanenkov VV; Cribbs DH; Agadjanyan MG
J Cell Biochem; 2006 Aug; 98(5):1037-43. PubMed ID: 16741971
[TBL] [Abstract][Full Text] [Related]
23. A cell cycle role for the epigenetic factor CTCF-L/BORIS.
Rosa-Garrido M; Ceballos L; Alonso-Lecue P; Abraira C; Delgado MD; Gandarillas A
PLoS One; 2012; 7(6):e39371. PubMed ID: 22724006
[TBL] [Abstract][Full Text] [Related]
24. Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells.
Rivero-Hinojosa S; Kang S; Lobanenkov VV; Zentner GE
Sci Rep; 2017 Feb; 7():41279. PubMed ID: 28145452
[TBL] [Abstract][Full Text] [Related]
25. BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites.
Pugacheva EM; Bhatt DN; Rivero-Hinojosa S; Tajmul M; Fedida L; Price E; Ji Y; Loukinov D; Strunnikov AV; Ren B; Lobanenkov VV
Genome Biol; 2024 Jan; 25(1):40. PubMed ID: 38297316
[TBL] [Abstract][Full Text] [Related]
26. The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis.
Rivero-Hinojosa S; Pugacheva EM; Kang S; Méndez-Catalá CF; Kovalchuk AL; Strunnikov AV; Loukinov D; Lee JT; Lobanenkov VV
Nat Commun; 2021 Jun; 12(1):3846. PubMed ID: 34158481
[TBL] [Abstract][Full Text] [Related]
27. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells.
Kang Y; Hong JA; Chen GA; Nguyen DM; Schrump DS
Oncogene; 2007 Jun; 26(30):4394-403. PubMed ID: 17260018
[TBL] [Abstract][Full Text] [Related]
28. CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region.
Nguyen P; Cui H; Bisht KS; Sun L; Patel K; Lee RS; Kugoh H; Oshimura M; Feinberg AP; Gius D
Cancer Res; 2008 Jul; 68(14):5546-51. PubMed ID: 18632606
[TBL] [Abstract][Full Text] [Related]
29. Expression analysis of BORIS during pluripotent, differentiated, cancerous, and non-cancerous cell states.
Soltanian S; Dehghani H; Matin MM; Bahrami AR
Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):647-58. PubMed ID: 24928684
[TBL] [Abstract][Full Text] [Related]
30. BORIS in human cancers -- a review.
Martin-Kleiner I
Eur J Cancer; 2012 Apr; 48(6):929-35. PubMed ID: 22019212
[TBL] [Abstract][Full Text] [Related]
31. The Diverging Routes of BORIS and CTCF: An Interactomic and Phylogenomic Analysis.
Jabbari K; Heger P; Sharma R; Wiehe T
Life (Basel); 2018 Jan; 8(1):. PubMed ID: 29385718
[TBL] [Abstract][Full Text] [Related]
32. A Common Polymorphism within the IGF2 Imprinting Control Region Is Associated with Parent of Origin Specific Effects in Infantile Hemangiomas.
Schultz B; Yao X; Deng Y; Waner M; Spock C; Tom L; Persing J; Narayan D
PLoS One; 2015; 10(10):e0113168. PubMed ID: 26496499
[TBL] [Abstract][Full Text] [Related]
33. Targeting CTCFL/BORIS for the immunotherapy of cancer.
Loukinov D
Cancer Immunol Immunother; 2018 Dec; 67(12):1955-1965. PubMed ID: 30390146
[TBL] [Abstract][Full Text] [Related]
34. Genetics and epigenetics of the multifunctional protein CTCF.
Filippova GN
Curr Top Dev Biol; 2008; 80():337-60. PubMed ID: 17950379
[TBL] [Abstract][Full Text] [Related]
35. Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma.
Macaluso M; Caracciolo V; Rizzo V; Sun A; Montanari M; Russo G; Bellipanni G; Khalili K; Giordano A
Cell Cycle; 2012 May; 11(9):1841-50. PubMed ID: 22544282
[TBL] [Abstract][Full Text] [Related]
36. BORIS/CTCFL expression activates the TGFβ signaling cascade and induces Drp1 mediated mitochondrial fission in neuroblastoma.
Makani VKK; Mendonza JJ; Edathara PM; Yerramsetty S; Pal Bhadra M
Free Radic Biol Med; 2021 Nov; 176():62-72. PubMed ID: 34534628
[TBL] [Abstract][Full Text] [Related]
37. Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation.
Nishana M; Ha C; Rodriguez-Hernaez J; Ranjbaran A; Chio E; Nora EP; Badri SB; Kloetgen A; Bruneau BG; Tsirigos A; Skok JA
Genome Biol; 2020 May; 21(1):108. PubMed ID: 32393311
[TBL] [Abstract][Full Text] [Related]
38. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma.
Loukinov DI; Pugacheva E; Vatolin S; Pack SD; Moon H; Chernukhin I; Mannan P; Larsson E; Kanduri C; Vostrov AA; Cui H; Niemitz EL; Rasko JE; Docquier FM; Kistler M; Breen JJ; Zhuang Z; Quitschke WW; Renkawitz R; Klenova EM; Feinberg AP; Ohlsson R; Morse HC; Lobanenkov VV
Proc Natl Acad Sci U S A; 2002 May; 99(10):6806-11. PubMed ID: 12011441
[TBL] [Abstract][Full Text] [Related]
39. Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer.
Damaschke NA; Yang B; Blute ML; Lin CP; Huang W; Jarrard DF
Neoplasia; 2014 Dec; 16(12):1018-27. PubMed ID: 25499215
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide copy number profiling using a 100K SNP array reveals novel disease-related genes BORIS and TSHZ1 in juvenile angiofibroma.
Schick B; Wemmert S; Willnecker V; Dlugaiczyk J; Nicolai P; Siwiec H; Thiel CT; Rauch A; Wendler O
Int J Oncol; 2011 Nov; 39(5):1143-51. PubMed ID: 21874228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]